相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [18F] fluspidine and [18F] fallypride PET study
Igor D. Grachev et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Sorcin is an early marker of neurodegeneration, Ca2+ dysregulation and endoplasmic reticulum stress associated to neurodegenerative diseases
Ilaria Genovese et al.
CELL DEATH & DISEASE (2020)
Effects of Pridopidine on Functional Capacity in Early-Stage Participants from the PRIDE-HD Study
Andrew McGarry et al.
JOURNAL OF HUNTINGTONS DISEASE (2020)
Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study
Ralf Reilmann et al.
LANCET NEUROLOGY (2019)
Pridopidine Induces Functional Neurorestoration Via the Sigma-1 Receptor in a Mouse Model of Parkinson's Disease
Veronica Francardo et al.
NEUROTHERAPEUTICS (2019)
Targeting the Sigma-1 Receptor via Pridopidine Ameliorates Central Features of ALS Pathology in a SOD1G93A Model
Ariel Ionescu et al.
CELL DEATH & DISEASE (2019)
Pridopidine stabilizes mushroom spines in mouse models of Alzheimer's disease by acting on the sigma-1 receptor
Daniel Ryskamp et al.
NEUROBIOLOGY OF DISEASE (2019)
A New Pharmacophore Model for the Design of Sigma-1 Ligands Validated on a Large Experimental Dataset
Rosalia Pascual et al.
FRONTIERS IN PHARMACOLOGY (2019)
Pridopidine protects neurons from mutant-huntingtin toxicity via the sigma-1 receptor
Chelsy R. Eddings et al.
NEUROBIOLOGY OF DISEASE (2019)
Small-Molecule Sigma1 Modulator Induces Autophagic Degradation of PD-L1
Christina M. Maher et al.
MOLECULAR CANCER RESEARCH (2018)
Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial
Jordi Bruna et al.
NEUROTHERAPEUTICS (2018)
DrugBank 5.0: a major update to the DrugBank database for 2018
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2018)
Critical role of sigma-1 receptors in central neuropathic pain-related behaviours after mild spinal cord injury in mice
Silvia Castany et al.
SCIENTIFIC REPORTS (2018)
Biological and clinical manifestations of juvenile Huntington's disease: a retrospective analysis
Caterina Fusilli et al.
LANCET NEUROLOGY (2018)
Structural basis for σ1 receptor ligand recognition
Hayden R. Schmidt et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
Mitochondrial alterations accompanied by oxidative stress conditions in skin fibroblasts of Huntington's disease patients
Paulina Jedrak et al.
METABOLIC BRAIN DISEASE (2018)
Bioenergetics in fibroblasts of patients with Huntington disease are associated with age at onset
Sarah L. Gardiner et al.
NEUROLOGY-GENETICS (2018)
The sigma-1 receptor modulates dopamine transporter conformation and cocaine binding and may thereby potentiate cocaine self-administration in rats
Weimin Conrad Hong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Resting-state connectivity and modulated somatomotor and default-mode networks in Huntington disease
Cristina Sanchez-Castaneda et al.
CNS NEUROSCIENCE & THERAPEUTICS (2017)
Pridopidine activates neuroprotective pathways impaired in Huntington Disease
Michal Geva et al.
HUMAN MOLECULAR GENETICS (2016)
Crystal structure of the human σ1 receptor
Hayden R. Schmidt et al.
NATURE (2016)
Biochemical Pharmacology of the Sigma-1 Receptor
Uyen B. Chu et al.
MOLECULAR PHARMACOLOGY (2016)
Pridopidine, a dopamine stabilizer, improves motor performance and shows neuroprotective effects in Huntington disease R6/2 mouse model
Ferdinando Squitieri et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
ZINC 15-Ligand Discovery for Everyone
Teague Sterling et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2015)
Role of sigma-1 receptors in neurodegenerative diseases
Linda Nguyen et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2015)
Structural basis of Sorcin-mediated calcium-dependent signal transduction
Andrea Ilari et al.
SCIENTIFIC REPORTS (2015)
Quantitative Interaction Proteomics of Neurodegenerative Disease Proteins
Fabian Hosp et al.
CELL REPORTS (2015)
Nilotinib-induced autophagic changes increase endogenous parkin level and ubiquitination, leading to amyloid clearance
Irina Lonskaya et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
Gene expression profile in fibroblasts of Huntington's disease patients and controls
Eleonora Marchina et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2014)
Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of -synuclein in Parkinsons disease models
Michaeline L. Hebron et al.
HUMAN MOLECULAR GENETICS (2013)
A review of current evidence for vilazodone in major depressive disorder
Sheng-Min Wang et al.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE (2013)
The dopamine stabilizers ACR16 and (-)-OSU6162 display nanomolar affinities at the sigma-1 receptor
K. Sahlholm et al.
MOLECULAR PSYCHIATRY (2013)
One-year safety and tolerability profile of pridopidine in patients with Huntington disease
Ferdinando Squitieri et al.
NEUROLOGY (2013)
A σ1 receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.02,6.03,10.05,9.08,11]dodecan-3-ols (AHDs)
Samuel D. Banister et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Sigma-1R Agonist Improves Motor Function and Motoneuron Survival in ALS Mice
Renzo Mancuso et al.
NEUROTHERAPEUTICS (2012)
Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders
Teruo Hayashi et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Open Babel: An open chemical toolbox
Noel M. O'Boyle et al.
JOURNAL OF CHEMINFORMATICS (2011)
Identification of Side Effects Associated With Intolerance to BCR-ABL Inhibitors in Patients With Chronic Myeloid Leukemia
Mary Beth Rios et al.
CLINICAL JOURNAL OF ONCOLOGY NURSING (2011)
The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Exhibits Time- and Dose-Dependent Localization in Kidney, Liver, and Intestine after Intravenous Dosing: Results from High Resolution Autoradiography in Rats
Andreas Greischel et al.
DRUG METABOLISM AND DISPOSITION (2010)
5D-QSAR for spirocyclic σ1 receptor ligands by Quasar receptor surface modeling
Christoph Oberdorf et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Virtual screening with AutoDock: theory and practice
Sandro Cosconati et al.
EXPERT OPINION ON DRUG DISCOVERY (2010)
Software News and Update AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading
Oleg Trott et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2010)
Abnormal morphology of peripheral cell tissues from patients with Huntington disease
Ferdinando Squitieri et al.
JOURNAL OF NEURAL TRANSMISSION (2010)
σ1 Receptor Modulation of G-Protein-Coupled Receptor Signaling: Potentiation of Opioid Transduction Independent from Receptor Binding
Felix J. Kim et al.
MOLECULAR PHARMACOLOGY (2010)
Network organization of the human autophagy system
Christian Behrends et al.
NATURE (2010)
Direct involvement of σ-1 receptors in the dopamine D1 receptor-mediated effects of cocaine
Gemma Navarro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The sigma-1 receptor chaperone as an inter-organelle signaling modulator
Tsung-Ping Su et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility
Garrett M. Morris et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
Synthesis, Biological Evaluation, and Three-Dimensional in Silico Pharmacophore Model for σ1 Receptor Ligands Based on a Series of Substituted Benzo[d]oxazol-2(3H)-one Derivatives
Daniele Zampieri et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Beyond the brain: widespread pathology in Huntington's disease
Jorien M. M. van der Burg et al.
LANCET NEUROLOGY (2009)
The pharmacology of sigma-1 receptors
Tangui Maurice et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Role of sigma-1 receptor C-terminal segment in inositol 1,4,5-trisphosphate receptor activation - Constitutive enhancement of calcium signaling in MCF-7 tumor cells
Zhiping Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
A semiempirical free energy force field with charge-based desolvation
Ruth Huey et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2007)
Oxidative stress in skin fibroblasts cultures of patients with Huntington's disease
Pilar del Hoyo et al.
NEUROCHEMICAL RESEARCH (2006)
Discovery of high-affinity ligands of σ1 receptor, ERG2, and emopamil binding protein by pharmacophore modeling and virtual screening
C Laggner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Huntington's disease: present treatments and future therapeutic modalities
RM Bonelli et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2004)
Drug repositioning: Identifying and developing new uses for existing drugs
TT Ashburn et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Molecular modeling of sigma 1 receptor ligands: a model of binding conformational and electrostatic considerations
TM Gund et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2004)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
The sigma receptor as a ligand-regulated auxiliary potassium channel subunit
E Aydar et al.
NEURON (2002)
Membrane-delimited coupling between sigma receptors and K+ channels in rat neurohypophysial terminals requires neither G-protein nor ATP
PJ Lupardus et al.
JOURNAL OF PHYSIOLOGY-LONDON (2000)
Rate of functional decline in Huntington's disease
K Marder et al.
NEUROLOGY (2000)
KEGG: Kyoto Encyclopedia of Genes and Genomes
M Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2000)
The Protein Data Bank
HM Berman et al.
NUCLEIC ACIDS RESEARCH (2000)
分享论文
